Smithbridge Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Smithbridge Asset Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.09M	Sell	4,175 -163	-4%	-$78.2K	0.29%	69
2026 Q1	$2.13M	Sell	4,338 -4,368	-50%	-$2.37M	0.32%	71
2025 Q4	$5.04M	Buy	8,706 +134	+2%	+$75.8K	0.43%	60
2025 Q3	$4.16M	Sell	8,572 -192	-2%	-$89.4K	0.6%	52
2025 Q2	$3.55M	Sell	8,764 -449	-5%	-$188K	0.62%	53
2025 Q1	$4.58M	Buy	+9,213	New	+$4.99M	0.85%	46
2024 Q3	$6.01M	Buy	9,721 +4,191	+76%	+$2.48M	1.04%	34
2024 Q2	$3.06M	Sell	5,530 -976	-15%	-$559K	0.64%	52
2024 Q1	$3.78M	Sell	6,506 -384	-6%	-$215K	0.78%	48
2023 Q4	$3.66M	Sell	6,890 -70	-1%	-$33.9K	0.83%	46
2023 Q3	$3.52M	Sell	6,960 -498	-7%	-$265K	0.87%	43
2023 Q2	$3.89M	Sell	7,458 -128	-2%	-$69.1K	0.91%	42
2023 Q1	$4.37M	Buy	7,586 +104	+1%	+$58.6K	1.1%	33
2022 Q4	$4.12M	Buy	+7,482	New	+$3.96M	1.1%	34

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Smithbridge Asset Management's TMO Position: Q2 2026 in Review

Smithbridge Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 3.8% in Q2 2026, selling an estimated $78.2K and leaving 4,175 shares worth $2.09M. The position accounts for 0.29% of the portfolio, ranked #69.

Smithbridge Asset Management first reported a position in TMO in Q4 2022 and has held it in 14 quarters since. The position peaked at $6.01M in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Smithbridge Asset Management held 4,175 shares of Thermo Fisher Scientific worth $2.09M as of Q2 2026.
Smithbridge Asset Management sold 163 Thermo Fisher Scientific shares in Q2 2026, an estimated $78.2K.
Thermo Fisher Scientific made up 0.29% of Smithbridge Asset Management's portfolio in Q2 2026, its #69 holding.
Smithbridge Asset Management first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 14 quarters since.
Smithbridge Asset Management's Thermo Fisher Scientific position peaked at $6.01M in Q3 2024.
2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Smithbridge Asset Management's 13F filing for Q2 2026, filed 20 Jul 2026.